Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections

NCT00408135 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections
Child

Interventions

DRUG: telithromycin (HMR3647)

Sponsor

Sanofi